Rise in Number of Neurosurgical Procedures
The growing prevalence of neurological disorders, including epilepsy, Parkinson’s disease, head injury, brain tumors, brain stroke, and hydrocephalus, raises the need for neurosurgeries. Also, several subspecialties of neurosurgery such as pediatric neurosurgery, functional neurosurgery, neurovascular surgery, traumatology, skull-base surgery, and spinal surgery are among the most technical and skilled areas of surgery.
As per the data published by Centers for Disease Control and Prevention (CDC), the US recorded ~223,135 traumatic brain injury (TBI)-related hospitalizations in 2019 and 64,362 TBI-related deaths in 2020. Also, as per an article published in 2022 in The Lancet entitled, every year a million new cases of TBI are reported in the region. TBI can be treated by neurosurgical procedures. Therefore, the rising cases of TBI due to several factors, including falls, sports injuries, road accidents, domestic violence, and military incidents, propel the demand for neurosurgical procedures.
According to World Health Organization (WHO) data published in June 2022, millions of people suffer from epilepsy, and it is one of the most common neurological diseases. Among all, nearly 80% of epilepsy patients are in low- and middle-income countries. The patients who poorly respond to drug treatment undergo surgery. Therefore, the growing incidence of epilepsy propels the need for neurosurgical procedures. Thus, increase in the number of neurosurgeries drives the growth of the North America neurosurgical robotics market.
Market Overview
The North America neurosurgical robotics market is segmented into the US, Canada, and Mexico. The US holds the largest share of the North American neurosurgical robotics market. The market in North America is expected to grow owing to the factors such as the wide availability of competitors, rising product approvals, rising prevalence of neurological disorders, coupled with an increasing number of neurosurgical procedures, and well-established healthcare infrastructure. The neurosurgical robotics market is further driven due to the surge in the adoption of neurosurgical robotics and increasing number of MIS procedures compared to conventional approaches, and players launching technologically advanced products in neurosurgery space.
The US is home to key market leaders in the medical device industry. Also, various international players have their manufacturing facilities across the country. These players are constantly involved in new product development, and thus, enabling the launch of various innovative products.
North America Neurosurgical Robotics Market Segmentation
The North America neurosurgical robotics market is segmented into component, application, surgery type, end user, and country.
Based on component, the North America neurosurgical robotics market is segmented into equipment/system, accessories, and services. The equipment/system segment is further segmented into robot machines, navigation system, planner & simulators, and others. The accessories segment is anticipated to hold the largest share of the market in 2022. The North America neurosurgical robotics market, based on application, is segmented into spinal and cranial. Spinal application is further segmented into spinal fusion, laminectomy, disc replacement, discectomy, foraminotomy, and others. The cranial segment is also subsegmented into brain biopsy, thermal ablation of seizure, surgical treatment of movement disorders, and others. In 2022, the spinal segment is anticipated to hold the largest share of the market, by application.
The North America neurosurgical robotics market, based on surgery type, is segmented into open and minimally invasive. In 2022, the minimally invasive segment is anticipated to hold a larger share of the market.
Based on end user, the North America neurosurgical robotics market is segmented into hospitals, specialty centers, and others. In 2022, the hospitals segment is anticipated to hold the largest share of the market. Based on country, the market is segmented into the US, Canada, and Mexico. The US is anticipated to dominate the market in 2022. Accuray Incorporated; B. Braun Melsungen AG; Brainlab AG; Globus Medical, Inc.; Medtronic; NuVasive, Inc.; NuVasive, Inc; Renishaw plc; Synaptive Medical, Inc.; and Zimmer Biomet are among the leading companies operating in the neurosurgical robotics market in the region.
| Report Attribute | Details |
|---|---|
| Market size in 2022 | US$ 797.59 Million |
| Market Size by 2028 | US$ 1,962.60 Million |
| CAGR (2022 - 2028) | 16.2% |
| Historical Data | 2020-2021 |
| Forecast period | 2023-2028 |
| Segments Covered |
By Component
|
|
Regions and Countries Covered
|
|
| North America | US, Canada, Mexico |
| Market leaders and key company profiles |
|
The North America Neurosurgical Robotics Market is valued at US$ 797.59 Million in 2022, it is projected to reach US$ 1,962.60 Million by 2028.
As per our report North America Neurosurgical Robotics Market, the market size is valued at US$ 797.59 Million in 2022, projecting it to reach US$ 1,962.60 Million by 2028. This translates to a CAGR of approximately 16.2% during the forecast period.
The North America Neurosurgical Robotics Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the North America Neurosurgical Robotics Market report:
The North America Neurosurgical Robotics Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The North America Neurosurgical Robotics Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the North America Neurosurgical Robotics Market value chain can benefit from the information contained in a comprehensive market report.
Please tell us your area of interest
(Market Segments/ Regions and Countries/ Companies)